OrbiMed’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,894,462
| Closed | -$11.4M | – | 110 |
|
|
2024
Q2 | $11.4M | Sell |
1,894,462
-823,508
| -30% | -$4.97M | 0.23% | 71 |
|
|
2024
Q1 | $30.3M | Sell |
2,717,970
-377,030
| -12% | -$4.2M | 0.56% | 50 |
|
|
2023
Q4 | $46.1M | Buy |
3,095,000
+224,000
| +8% | +$3.34M | 0.92% | 41 |
|
|
2023
Q3 | $13.8M | Hold |
2,871,000
| – | – | 0.29% | 71 |
|
|
2023
Q2 | $21.6M | Hold |
2,871,000
| – | – | 0.39% | 68 |
|
|
2023
Q1 | $13M | Hold |
2,871,000
| – | – | 0.25% | 79 |
|
|
2022
Q4 | $32.4M | Hold |
2,871,000
| – | – | 0.62% | 54 |
|
|
2022
Q3 | $27.5K | Buy |
2,871,000
+684,731
| +31% | +$6.55K | 0.51% | 61 |
|
|
2022
Q2 | $17.7K | Buy |
2,186,269
+1,564,569
| +252% | +$12.7K | 0.32% | 68 |
|
|
2022
Q1 | $10.5M | Buy |
621,700
+414,100
| +199% | +$7M | 0.17% | 99 |
|
|
2021
Q4 | $4.46M | Buy |
207,600
+57,600
| +38% | +$1.24M | 0.06% | 138 |
|
|
2021
Q3 | $11.1M | Hold |
150,000
| – | – | 0.12% | 123 |
|
|
2021
Q2 | $8.2M | Hold |
150,000
| – | – | 0.08% | 132 |
|
|
2021
Q1 | $11.1M | Hold |
150,000
| – | – | 0.1% | 118 |
|
|
2020
Q4 | $12.9M | Buy |
+150,000
| New | +$12.9M | 0.11% | 117 |
|